Citation

Gowda GS, Das S, Nanjegowda RB. Asian J. Psychiatry 2017; 30: 214-217.

Affiliation

Department of Psychiatry, Dharwad Institute of Mental Health and Neurosciences (DIMHANS), Belgaum Road, Dharwad 580008, India.

Copyright

(Copyright © 2017, Elsevier Publishing)

DOI

10.1016/j.ajp.2017.03.035

PMID

28410867

Abstract

Non-adherence to oral psychotropic medications is common in patients with severe mental illness (SMI). This substantially limits the effectiveness of treatment and results in higher rates of relapse, rehospitalization, suicide, early mortality and disability in SMI. This is a major concern for professionals, caregivers and policy makers. The pharmacological, psychological, psychosocial models and interventions have been there since last few decades to address non-adherence. These have not made major changes in treatment adherence and outcome of SMI. Hence new powerful, long acting and novel psychotropic implant can be developed and could soon revolutionize the treatment in psychiatry.

Copyright © 2017 Elsevier B.V. All rights reserved.

Language: en

Keywords

Adherence; Novel treatment; Psychiatry; Psychotropic implant